Skip to main content

Author: Leigh MacMillan

Inflammation implicated in exfoliation syndrome

Mar. 28, 2023—Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness.

Read more


Improving lung nodule diagnosis

Mar. 27, 2023—Adding blood and imaging biomarkers to a clinical prediction model could improve diagnostic accuracy for the 1.6 million lung nodules detected each year, many through expanded lung cancer screening programs.

Read more


Mathers Foundation award supports study of bacterial physiology

Mar. 23, 2023—Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases.

Read more


Study evaluates polygenic risk score for prostate cancer risk prediction

Mar. 16, 2023—A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

Read more


Treating delirium detected in the ED

Mar. 7, 2023—Higher intensity physical or occupational therapy may be a useful intervention to shorten delirium duration in older hospitalized adults, Vanderbilt researchers recently reported.

Read more


Cell-free hemoglobin in pulmonary hypertension

Mar. 6, 2023—Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.

Read more


Discovery lecture features electron microscopy leader Cheng

Feb. 28, 2023—Yifan Cheng, PhD, a leader in electron microscopy technology development and structural studies of biological macromolecules, will deliver the next Discovery Lecture on Thursday, March 9.

Read more


Bastarache takes on new role for research career development

Feb. 23, 2023—Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center.

Read more


Probing hellbender health

Feb. 20, 2023—Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.

Read more


Breast cancer genetics: new insights

Feb. 16, 2023—Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.

Read more


Gut microbiota and lung fibrosis

Feb. 6, 2023—Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.

Read more


Nutrient absorption disease model

Feb. 2, 2023—Vanderbilt researchers developed a model of a patient-specific mutation to explore the pathology of microvillus inclusion disease, a genetic disorder that causes life-threatening diarrhea.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more